MYELOMA SPOTLIGHT
This collection is brought to you via an educational grant by Celgene.
This series of review articles covers recent advances in the biology and treatment of multiple myeloma. The series also includes authoritative consensus statements on controversial and evolving areas including diagnostic and response criteria, molecular classification, and new laboratory tests. These reviews will be an invaluable resource for practicing clinicians, laboratory scientists, and other hematologists.
Editorial |2009 |
2008
Editorial
Spotlight review series on multiple myeloma FREE
S V Rajkumar, N M-B Killmann
Leukemia 23: R1-R2; doi:10.1038/leu.2009.243
2009
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma FREE
R A Kyle and S V Rajkumar
Leukemia 23: 3-9; advance online publication, October 30, 2008; doi:10.1038/leu.2008.291
Bone marrow microenvironment and the identification of new targets for myeloma therapy FREE
K Podar, D Chauhan and K C Anderson
Leukemia 23: 10-24; advance online publication, October 9, 2008; doi:10.1038/leu.2008.259
Treatment of newly diagnosed myeloma FREE
A Palumbo and S V Rajkumar
Leukemia 23: 449-456; advance online publication, November 13, 2008; doi:10.1038/leu.2008.325
Role of autologous and allogeneic stem cell transplantation in myeloma FREE
W I Bensinger
Leukemia 23: 442-448; advance online publication, January 29, 2009; doi:10.1038/leu.2008.396
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders FREE
A Dispenzieri, R Kyle, G Merlini, J S Miguel, H Ludwig, R Hajek, A Palumbo, S Jagannath, J Blade, S Lonial, M Dimopoulos, R Comenzo, H Einsele, B Barlogie, K Anderson, M Gertz, J L Harousseau, M Attal, P Tosi, P Sonneveld, M Boccadoro, G Morgan, P Richardson, O Sezer, M V Mateos, M Cavo, D Joshua, I Turesson, W Chen, K Shimizu, R Powles, S V Rajkumar and B G M Durie on behalf of the International Myeloma Working Group
Leukemia 23: 215-224; advance online publication, November 20, 2008; doi:10.1038/leu.2008.307
Pathogenesis of myeloma bone disease FREE
G D Roodman
Leukemia 23: 435-441; advance online publication, November 27, 2008; doi:10.1038/leu.2008.336
Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis FREE
O Landgren and B M Weiss
Leukemia advance online publication, July 9, 2009; doi:10.1038/leu.2009.134
The molecular characterization and clinical management of multiple myeloma in the post-genome era FREE
Y Zhou, B Barlogie and J D Shaughnessy Jr
Leukemia advance online publication, August 6, 2009; doi:10.1038/leu.2009.160
The use of novel agents in the treatment of relapsed and refractory multiple myeloma FREE
J P Laubach, A Mahindra, C S Mitsiades, R L Schlossman, N C Munshi, I M Ghobrial, N Carreau, T Hideshima, K C Anderson and P G Richardson
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.179
Proteasome inhibitors in the treatment of multiple myeloma FREE
J J Shah and R Z Orlowski
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.173
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review FREE
R Fonseca, P L Bergsagel, J Drach, J Shaughnessy, N Gutierrez, K Stewart, G Morgan, B Van Ness, M Chesi, S Minvielle, A Neri, B Barlogie, W M Kuehl, P Liebisch, F Davies, S Chen-Kiang, B G M Durie, R Carrasco, Orhan Sezer, Tony Reiman, Linda Pilarski and H Avet-Loiseau
Leukemia advance online publication, October 1, 2009; doi:10.1038/leu.2009.174
2008
Pathogenesis and treatment of renal failure in multiple myeloma FREE
M A Dimopoulos, E Kastritis, L Rosinol, J Bladé and H Ludwig
Leukemia 22: 1485-1493; advance online publication, June 5, 2008; doi:10.1038/leu.2008.131
Treatment of plasma cell dyscrasias with lenalidomide FREE
M A Dimopoulos, E Kastritis and S V Rajkumar
Leukemia 22: 1343-1353; advance online publication, May 29, 2008; doi:10.1038/leu.2008.123
© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.
